Why the study?
Does intensive glucose control reduce all-cause mortality, non-fatal myocardial infarction, and non-fatal stroke in patients with type 2 diabetes?
Population
27,544 patients with type 2 diabetes from 4 randomised trials (6 reports)
Comparison
Intensive glucose control vs Conventional glucose control
Design
Meta-analysis
Follow-up
mean 5.4 years
Authors
Loading...
Supports intensive glucose control to reduce non-fatal MI in type 2 diabetes; confirms no mortality or stroke benefit.
Does intensive glucose control reduce all-cause mortality, non-fatal myocardial infarction, and non-fatal stroke in patients with type 2 diabetes?
Intensive glucose control in type 2 diabetes reduces the risk of non-fatal myocardial infarction but does not significantly impact all-cause mortality or stroke.
Marso et al. (2009) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: